|
Acquisition of Pharmasset, Inc. Cash Consideration Paid in Acquisition (Details) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2012
|
Jan. 17, 2012
|
|
| Business Combinations [Abstract] | ||
| Business Combination, Consideration Transferred | $ 10,858,372 | $ 10,858,372 |
| Accelerated Stock-Based Compensation | 193,937 | |
| Business Acquisition, Cost of Acquired Entity, Cash Paid | $ 11,052,309 | $ 11,100,000 |
| X | ||||||||||
|
- Definition
This element represents the stock-based compensation expense recognized for the accelerated vesting of acquiree stock-based awards immediately prior to the acquisition No definition available.
|
| X | ||||||||||
|
- Definition
Amount of cash paid to acquire the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the acquisition-date fair value of the total consideration transferred which consists of the sum of the acquisition-date fair values of the assets transferred by the acquirer, the liabilities incurred by the acquirer to former owners of the acquiree, and the equity interests issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|